Skip to Main Content

Paper Details

Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Nat Genet
118
2018
-derived, EGFR, PDCs, cancer, cancer cell line models, gliomas, hematological malignancies, ibrutinib, long, patient, patient-derived tumor cells, patients, tumor, tumor cells, tumors
Antineoplastic Agents, Biomarkers, Pharmacological, Biomarkers, Tumor, Cell Lineage, Drug Resistance, Neoplasm, Drug Screening Assays, Antitumor, Feasibility Studies, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, HEK293 Cells, Humans, Medical Oncology, Molecular Targeted Therapy, Neoplasms, Panobinostat, Patient-Centered Care, Pharmacogenetics, Precision Medicine, Primary Cell Culture, Tumor Cells, Cultured
Author NameAffiliation
Jin-Ku LeeInstitute for Refractory Cancer Research, Samsung Medical Center
Jin-Ku LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Jin-Ku LeeResearch Institute for Future Medicine, Samsung Medical Center
Zhaoqi LiuColumbia University
Zhaoqi LiuColumbia University
Jason K SaInstitute for Refractory Cancer Research, Samsung Medical Center
Jason K SaResearch Institute for Future Medicine, Samsung Medical Center
Sang ShinInstitute for Refractory Cancer Research, Samsung Medical Center
Sang ShinSamsung Advanced Institute for Health Science and Technology, Sungkyunkwan University
Jiguang WangHong Kong University of Science and Technology
Jiguang WangHong Kong University of Science and Technology
Jiguang WangHong Kong University of Science and Technology
Mykola BordyuhColumbia University
Mykola BordyuhColumbia University
Hee Jin ChoInstitute for Refractory Cancer Research, Samsung Medical Center
Hee Jin ChoResearch Institute for Future Medicine, Samsung Medical Center
Oliver ElliottColumbia University
Oliver ElliottColumbia University
Timothy ChuColumbia University
Timothy ChuColumbia University
Seung Won ChoiInstitute for Refractory Cancer Research, Samsung Medical Center
Seung Won ChoiSamsung Advanced Institute for Health Science and Technology, Sungkyunkwan University
Daniel I S RosenbloomColumbia University
Daniel I S RosenbloomColumbia University
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeResearch Institute for Future Medicine, Samsung Medical Center
In-Hee LeeInstitute for Refractory Cancer Research, Samsung Medical Center
In-Hee LeeResearch Institute for Future Medicine, Samsung Medical Center
Yong Jae ShinInstitute for Refractory Cancer Research, Samsung Medical Center
Yong Jae ShinSamsung Medical Center, Sungkyunkwan University School of Medicine
Yong Jae ShinResearch Institute for Future Medicine, Samsung Medical Center
Hyun Ju KangInstitute for Refractory Cancer Research, Samsung Medical Center
Hyun Ju KangResearch Institute for Future Medicine, Samsung Medical Center
Donggeon KimInstitute for Refractory Cancer Research, Samsung Medical Center
Donggeon KimResearch Institute for Future Medicine, Samsung Medical Center
Sun Young KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Moon-Hee SimSamsung Medical Center, Sungkyunkwan University School of Medicine
Jusun KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Taehyang LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Yun Jee SeoInstitute for Refractory Cancer Research, Samsung Medical Center
Yun Jee SeoResearch Institute for Future Medicine, Samsung Medical Center
Hyemi ShinInstitute for Refractory Cancer Research, Samsung Medical Center
Hyemi ShinSamsung Advanced Institute for Health Science and Technology, Sungkyunkwan University
Mijeong LeeInstitute for Refractory Cancer Research, Samsung Medical Center
Mijeong LeeSamsung Advanced Institute for Health Science and Technology, Sungkyunkwan University
Sung Heon KimInstitute for Refractory Cancer Research, Samsung Medical Center
Sung Heon KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Yong-Jun KwonInstitute for Refractory Cancer Research, Samsung Medical Center
Jeong-Woo OhInstitute for Refractory Cancer Research, Samsung Medical Center
Jeong-Woo OhSamsung Advanced Institute for Health Science and Technology, Sungkyunkwan University
  • 1 - 50

Datasets